Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Mr. Gordon has been personally touched by the challenges of inattention and the pain it causes to children and families, and founded Atentiv to help the millions of families with a similar need. Prior to Atentiv, Mr. Gordon has had a long and successful track record of identifying and bringing emerging medical and healthcare technologies into the
clinic, industry and major market dominance. Over the last 25+ years, he has initiated, driven and managed through full development and/or full global commercialization seven startup companies in pediatric, adult and traveler's vaccines (Connaught Labs --now Sanofi-Pasteur, the largest global vaccine company, and Virogenetics); in combinatorial chemistry for drug discovery/IPO (ArQule); in clinical genomics for drug discovery and diagnostics (Ardais); in drug-delivery for endometriosis and other women’s health applications (Combinent); in HDL/CHD therapeutics and clinical models (Cardium); and in behavioral health/ADHD diagnostics (BioBehavioral Diagnostics).
Mr. Gordon began his career with Arthur Andersen & Co., and served as VP and Chief Financial Officer at Sterling Drug before leaving the pharmaceutical industry to fulfill his ambition to develop new technologies.
Eric holds business degrees in finance from Syracuse University, the University of Pennsylvania, and The Wharton School. He is also a CPA.
